Multiple endocrine neoplasia type 2: From molecular genetics to precision therapy

This publication has 99 references indexed in Scilit:

• Temporal trends in referrals of RET gene carriers for neck surgery to a tertiary surgical center in the era of international management guidelines
  Endocrine, 2022
• MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives
  Endocrine, 2020
• Clinical utility of ¹⁷⁷Lu‐DOTATATE PRRT in somatostatin receptor‐positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity
  Head & Neck, 2019
• EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
  European Journal of Nuclear Medicine and Molecular Imaging, 2019
• Genotype-specific progression of hereditary medullary thyroid cancer
  Human Mutation, 2018
• Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress
  Current Oncology Reports, 2017
• Pheochromocytoma in an 8‐year‐old patient with multiple endocrine neoplasia type 2A: Implications for screening
  Journal of Surgical Oncology, 2013
• Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10
  Human Mutation, 2010
• The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2
  JAMA, 1996
• Multiple mucosal neuromata with endocrine tumours: A syndrome allied to von Recklinghausen's disease
  The Journal of Pathology and Bacteriology, 1966